Back to Resource Library
By Joaquim Vives, PhDBanc de Sang i TeixitsBarcelona, SpainContributing editor Dr. Joaquim Vives provides his thoughts on an inspiring discussion started at ISCT 2021:The transformation of starting materials into safe and efficacious medicines involves numerous stakeholders and manufacturing steps, and is subject to stringent regulatory and quality control.As the cell therapy industry matures, variability across all steps of the production process must be reduced.And the first step is: the sourcing of starting materials.#ISCT2021#TranslationalScience#ManufacturingandScaleUp#28.3#28.3#ISCT2021